These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20645913)

  • 21. Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer.
    Attia YM; El-Kersh DM; Ammar RA; Adel A; Khalil A; Walid H; Eskander K; Hamdy M; Reda N; Mohsen NE; Al-Toukhy GM; Mansour MT; Elmazar MM
    Chem Biol Interact; 2020 Jan; 315():108865. PubMed ID: 31628941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.
    Zhang H; Patel A; Wang YJ; Zhang YK; Kathawala RJ; Qiu LH; Patel BA; Huang LH; Shukla S; Yang DH; Ambudkar SV; Fu LW; Chen ZS
    Mol Cancer Ther; 2017 Jun; 16(6):1021-1030. PubMed ID: 28265007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1.
    Zhao L; Jin X; Xu Y; Guo Y; Liang R; Guo Z; Chen T; Sun Y; Ding X
    J Exp Clin Cancer Res; 2010 Jul; 29(1):98. PubMed ID: 20642825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.
    Dong X; Mattingly CA; Tseng MT; Cho MJ; Liu Y; Adams VR; Mumper RJ
    Cancer Res; 2009 May; 69(9):3918-26. PubMed ID: 19383919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.
    Yang X; Yang P; Shen J; Osaka E; Choy E; Cote G; Harmon D; Zhang Z; Mankin H; Hornicek FJ; Duan Z
    Br J Cancer; 2014 Jun; 110(12):2896-904. PubMed ID: 24853187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifunctional nanoparticles based on a single-molecule modification for the treatment of drug-resistant cancer.
    Wang D; Tang J; Wang Y; Ramishetti S; Fu Q; Racette K; Liu F
    Mol Pharm; 2013 Apr; 10(4):1465-9. PubMed ID: 23473373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel (-)-arctigenin derivatives inhibit signal transducer and activator of transcription 3 phosphorylation and P-glycoprotein function resensitizing multidrug resistant cancer cells in vitro and in vivo.
    Yu KH; Kuo CY; Wu IT; Chi CH; Tsai KC; Kuo PC; Zeng JW; Hung CC; Hung HY
    Eur J Pharmacol; 2023 Dec; 960():176146. PubMed ID: 37884184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dual pH-sensitive liposomal system with charge-reversal and NO generation for overcoming multidrug resistance in cancer.
    Chen M; Song F; Liu Y; Tian J; Liu C; Li R; Zhang Q
    Nanoscale; 2019 Mar; 11(9):3814-3826. PubMed ID: 30600823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A light in multidrug resistance: photodynamic treatment of multidrug-resistant tumors.
    Capella MA; Capella LS
    J Biomed Sci; 2003; 10(4):361-6. PubMed ID: 12824695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapeutic potential of plant alkaloids and multidrug resistance mechanisms in malignant fibrous histiocytoma of the heart.
    Reinecke P; Steckstor M; Schmitz M; Gabbert HE; Gerharz CD
    Oncol Rep; 2004 Mar; 11(3):641-5. PubMed ID: 14767515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation.
    Yusuf RZ; Duan Z; Lamendola DE; Penson RT; Seiden MV
    Curr Cancer Drug Targets; 2003 Feb; 3(1):1-19. PubMed ID: 12570657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1.
    Wu CP; Hsiao SH; Sim HM; Luo SY; Tuo WC; Cheng HW; Li YQ; Huang YH; Ambudkar SV
    Biochem Pharmacol; 2013 Oct; 86(7):904-13. PubMed ID: 23962445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
    Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
    Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18FDG, [18F]FLT, [18F]FAZA, and 11C-methionine are suitable tracers for the diagnosis and in vivo follow-up of the efficacy of chemotherapy by miniPET in both multidrug resistant and sensitive human gynecologic tumor xenografts.
    Trencsényi G; Márián T; Lajtos I; Krasznai Z; Balkay L; Emri M; Mikecz P; Goda K; Szalóki G; Juhász I; Németh E; Miklovicz T; Szabó G; Krasznai ZT
    Biomed Res Int; 2014; 2014():787365. PubMed ID: 25309926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer.
    Talekar M; Ouyang Q; Goldberg MS; Amiji MM
    Mol Cancer Ther; 2015 Jul; 14(7):1521-31. PubMed ID: 25964202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.
    Wang YJ; Kathawala RJ; Zhang YK; Patel A; Kumar P; Shukla S; Fung KL; Ambudkar SV; Talele TT; Chen ZS
    Biochem Pharmacol; 2014 Aug; 90(4):367-78. PubMed ID: 24937702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zhankuic Acids A, B and C from
    Teng YN; Wang YH; Wu TS; Hung HY; Hung CC
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413
    [No Abstract]   [Full Text] [Related]  

  • 39. Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism.
    Bergman PJ; Gravitt KR; Ward NE; Beltran P; Gupta KP; O'Brian CA
    Invest New Drugs; 1997; 15(4):311-8. PubMed ID: 9547673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
    Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
    Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.